| Masking the immunotoxicity of interleukin-12 by fusing it with a domain of its receptor via a tumour-protease-cleavable linker A Mansurov, P Hosseinchi, K Chang, AL Lauterbach, LT Gray, AT Alpar, ... Nature Biomedical Engineering 6 (7), 819-829, 2022 | 41 | 2022 |
| Immunoengineering approaches for cytokine therapy A Mansurov, A Lauterbach, E Budina, AT Alpar, JA Hubbell, J Ishihara American Journal of Physiology-Cell Physiology 321 (2), C369-C383, 2021 | 21 | 2021 |
| Suppression of rheumatoid arthritis by enhanced lymph node trafficking of engineered interleukin‐10 in murine models E Yuba, E Budina, K Katsumata, A Ishihara, A Mansurov, AT Alpar, ... Arthritis & Rheumatology 73 (5), 769-778, 2021 | 20 | 2021 |
| Tumor cell-surface binding of immune stimulating polymeric glyco-adjuvant via cysteine-reactive pyridyl disulfide promotes antitumor immunity AJ Slezak, A Mansurov, MM Raczy, K Chang, AT Alpar, AL Lauterbach, ... ACS Central Science 8 (10), 1435-1446, 2022 | 13 | 2022 |
| Synthetically mannosylated antigens induce antigen-specific humoral tolerance and reduce anti-drug antibody responses to immunogenic biologics RP Wallace, KC Refvik, JT Antane, K Brünggel, AC Tremain, MR Raczy, ... Cell Reports Medicine 5 (1), 2024 | 1 | 2024 |
| Mannose‐Decorated Co‐Polymer Facilitates Controlled Release of Butyrate to Accelerate Chronic Wound Healing AL Lauterbach, AJ Slezak, R Wang, S Cao, MM Raczy, EA Watkins, ... Advanced Healthcare Materials 12 (26), 2300515, 2023 | 1 | 2023 |
| Anti-inflammatory cytokines and methods of use JA Hubbell, Y Eiji, E Watkins, J Ishihara, A Ishihara, E Budina, ... US Patent App. 18/246,512, 2024 | | 2024 |
| Cysteine-binding adjuvant enhances survival and promotes immune function in a murine model of acute myeloid leukemia AJ Slezak, K Chang, TN Beckman, KC Refvik, AT Alpar, AL Lauterbach, ... Blood Advances, bloodadvances. 2023012529, 2024 | | 2024 |
| Engineered Flt3L Drives Tolerogenic State to Attenuate Anti-drug Antibody Responses AT Alpar, RP Wallace, KC Refvik, S Gomes, A Solanki, LT Gray, AJ Slezak, ... bioRxiv, 2024.03. 21.586168, 2024 | | 2024 |
| Topically-applied collagen-binding serum albumin-fused interleukin-4 modulates wound microenvironment in non-healing wounds AL Lauterbach, RP Wallace, AT Alpar, KC Refvik, JW Reda, A Ishihara, ... NPJ Regenerative Medicine 8 (1), 49, 2023 | | 2023 |
| Author Correction: Topically-applied collagen-binding serum albumin-fused interleukin-4 modulates wound microenvironment in non-healing wounds AL Lauterbach, RP Wallace, AT Alpar, KC Refvik, JW Reda, A Ishihara, ... NPJ Regenerative Medicine 8, 2023 | | 2023 |
| Engineering Approaches for the Treatment of Non-healing Diabetic Wounds AL Lauterbach The University of Chicago, 2023 | | 2023 |
| Enhanced lymph node trafficking of engineered IL-10 suppresses rheumatoid arthritis in murine models E Budina, A Ishihara, A Mansurov, AT Alpar, EA Watkins, P Hosseinchi, ... | | |
